Ana By IFA (Anti Nuclear Antibody) Serum

1,300.00

NA By IFA (Antinuclear Antibody by Immunofluorescence Assay) is the gold standard screening test for detecting autoimmune antibodies in the blood. It helps identify systemic autoimmune diseases like lupus, Sjogren’s, and scleroderma by visually showing patterns of antibodies attacking cell nuclei.

SKU: GD53 Category:

Description

Antinuclear Antibodies (ANAs) are a type of autoantibody produced by the immune system that mistakenly attacks the body’s own healthy tissues—specifically the nucleus of the cell. The Immunofluorescence Assay (IFA) is a critical method for detecting these antibodies. In this assay, patient serum is added to a substrate (typically HEp-2 cells) and allowed to incubate. If ANAs are present, they bind to the cell nuclei. A fluorescently labeled antibody is then added, which binds to the patient’s antinuclear antibodies, causing them to glow under a fluorescence microscope.

Clinical Significance:

  • Gold Standard Method: IFA is considered the premier method for ANA testing due to its high sensitivity and ability to provide qualitative information (staining patterns).
  • Autoimmune Screening: It is the primary screening test used to detect Systemic Lupus Erythematosus (SLE), Sjogren’s Syndrome, Scleroderma, Mixed Connective Tissue Disease (MCTD), and other systemic connective tissue disorders.
  • Pattern Analysis: The pattern of the fluorescent staining (e.g., homogeneous, speckled, nucleolar, centromere) often corresponds to specific types of autoantibodies and can help differentiate between various autoimmune conditions. For example, a “speckled” pattern is common in Sjogren’s, while “homogenous” is frequently seen in SLE.
  • Rule-Out Test: A negative ANA by IFA test result is strong evidence that systemic autoimmune disease is not present. A positive result is followed by more specific ENA panels (Extractable Nuclear Antigen) to identify the precise antibody.

When is this test recommended?

Healthcare providers order an ANA By IFA test when a patient presents with symptoms that suggest a systemic autoimmune disease, including:

  • Unexplained joint pain, stiffness, or swelling.
  • Persistent fatigue and low-grade fever with no known cause.
  • Skin rashes (like the classic butterfly rash across the nose and cheeks).
  • Sensitivity to sunlight.
  • Muscle pain and weakness.
  • Hair loss.
  • Raynaud’s phenomenon (numbness or color changes in fingers/toes due to cold).

Sample Requirements:

  • Specimen: Blood (Serum).
  • Container: A standard Gold-top Serum Separator Tube (SST) or a Red-top tube. The SST tube contains a separation gel that is visible between the blood clot and the clear serum.

Patient Preparation:

  • No specific fasting is generally required for this test. Patients can eat and drink normally, but should inform their healthcare provider about all current medications, as some can induce a drug-induced lupus-like syndrome and cause a positive ANA result.